Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IIa Randomized Controlled Trial of Acetaminophen for the Reduction of Oxidative Stress in Severe Sepsis

NCT01739361 is registered in ClinicalTrials.gov with Vanderbilt University as lead sponsor.

NCT NCT01739361
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01739361 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IIa Randomized Controlled Trial of Acetaminophen for the Reduction of Oxidative Stress in Severe Sepsis
Lead sponsor
Vanderbilt University
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2013
Completion date
December 31, 2013
Enrollment
44 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

severe sepsis